anaptysbio.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://www.anaptysbio.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Home -
Description AnaptysBio - AnaptysBio is a clinical-stage antibody development company advancing therapeutic antibody product candidates focused on unmet medical needs in
Keywords N/A
Server Information
WebSite anaptysbio faviconanaptysbio.com
Host IP 162.159.134.42
Location United States
Related Websites
Site Rank
More to Explore
anaptysbio.com Valuation
US$23,431,011
Last updated: 2023-05-07 18:28:09

anaptysbio.com has Semrush global rank of 451,722. anaptysbio.com has an estimated worth of US$ 23,431,011, based on its estimated Ads revenue. anaptysbio.com receives approximately 2,703,579 unique visitors each day. Its web server is located in United States, with IP address 162.159.134.42. According to SiteAdvisor, anaptysbio.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$23,431,011
Daily Ads Revenue US$21,629
Monthly Ads Revenue US$648,859
Yearly Ads Revenue US$7,786,306
Daily Unique Visitors 180,239
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
anaptysbio.com. A 299 IP: 162.159.134.42
anaptysbio.com. NS 86400 NS Record: ns-1163.awsdns-17.org.
anaptysbio.com. NS 86400 NS Record: ns-13.awsdns-01.com.
anaptysbio.com. NS 86400 NS Record: ns-1831.awsdns-36.co.uk.
anaptysbio.com. NS 86400 NS Record: ns-732.awsdns-27.net.
anaptysbio.com. MX 900 MX Record: 0 anaptysbio-com.mail.protection.outlook.com.
anaptysbio.com. TXT 300 TXT Record: gd1ctjm84kyjkcmr9h10rpnhgqh41z80
anaptysbio.com. TXT 300 TXT Record: google-site-verification=WRDMOY-Fw0AghcpexsBvccXn_aiorwKsyUxNAPuPN3E
anaptysbio.com. TXT 300 TXT Record: google-site-verification=wQQp_hrzobvM4IOo0H3NAFU6MzFebqLQ8q4JUS4akzE
anaptysbio.com. TXT 300 TXT Record: v=spf1 ip4:12.215.150.74 include:spf.protection.outlook.com include:amazonses.com include:servers.mcsv.net -all
HtmlToTextCheckTime:2023-05-07 18:28:09
AnaptysBio - Home About Overview Strategy Senior Leadership Board of Directors Scientific Advisory Board Contact Technology Therapeutic Antibodies Somatic Hypermutation SHM Platform Key Advantages Publications Pipeline Overview Rosnilimab ANB032 ANB033 Imsidolimab Partnerships Investors / News Overview News Events Presentations Goverance Stock Information Analyst Coverage SEC Filings Investor FAQs Contact Careers Overview Job Openings Core Values Total Rewards Program Highlights AnaptysBio Culture Contact Toggle --> Transforming patient health by delivering innovative immunology therapeutics May 2, 2023 AnaptysBio Announces British Journal of Dermatology Publication of Imsidolimab (IL-36R) Previously Reported Phase 2 GALLOP Data in Generalized Pustular Psoriasis (GPP) AnaptysBio Announces British Journal of Dermatology Publication of Imsidolimab (IL-36R) Previously Reported Phase 2 GALLOP Data in Generalized Pustular Psoriasis (GPP) April 6, 2023 AnaptysBio Announces Appointment of
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Thu, 28 Oct 2021 13:02:50 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
Location: https://www.anaptysbio.com/
CF-Ray: 6a545c5f1b31f216-ORD
Cache-Control: max-age=3600
Expires: Thu, 28 Oct 2021 14:02:50 GMT
CF-Cache-Status: DYNAMIC
ki-edge: v=16.5
X-Content-Type-Options: nosniff
X-Edge-Location-Klb: 1
X-Kinsta-Cache: MISS
X-Redirect-By: WordPress
Server: cloudflare
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Thu, 28 Oct 2021 13:02:51 GMT
content-type: text/html; charset=UTF-8
cf-ray: 6a545c60bca06390-ORD
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
vary: Accept-Encoding
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
ki-edge: v=16.5
x-content-type-options: nosniff
x-edge-location-klb: 1
x-kinsta-cache: HIT
server: cloudflare
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400
anaptysbio.com Whois Information
Domain Name: ANAPTYSBIO.COM
Registry Domain ID: 251779092_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.name.com
Registrar URL: http://www.name.com
Updated Date: 2021-05-11T05:58:21Z
Creation Date: 2005-11-09T22:58:53Z
Registry Expiry Date: 2022-11-09T11:59:59Z
Registrar: Name.com, Inc.
Registrar IANA ID: 625
Registrar Abuse Contact Email: abuse@name.com
Registrar Abuse Contact Phone: 7202492374
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS-1163.AWSDNS-17.ORG
Name Server: NS-13.AWSDNS-01.COM
Name Server: NS-1831.AWSDNS-36.CO.UK
Name Server: NS-732.AWSDNS-27.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T05:32:40Z <<<